Φορτώνει......
Efficacy of Regorafenib in Metastatic Colorectal Cancer: A Multi-institutional Retrospective Study
BACKGROUND: Regorafenib is a multi-kinase inhibitor approved for treatment of refractory advanced colorectal cancer. It was found in the clinical trials to have a modest benefit and significant toxicity. Our aim was to assess the outcome in our local clinic practice. PATIENTS AND METHODS: Records of...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Clin Med Insights Oncol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
SAGE Publications
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6354297/ https://ncbi.nlm.nih.gov/pubmed/30728734 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179554918825447 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|